Čermák J - Search Results

1

Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.

Hlaváčková A, Štikarová J, Pimková K, Chrastinová L, Májek P, Kotlín R, Čermák J, Suttnar J, Dyr JE. Hlaváčková A, et al. Among authors: cermak j. Free Radic Biol Med. 2017 Jul;108:1-7. doi: 10.1016/j.freeradbiomed.2017.03.007. Epub 2017 Mar 12. Free Radic Biol Med. 2017. PMID: 28300669

2

A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.

Cermák J, Michalová K, Brezinová J, Zemanová Z. Cermák J, et al. Leuk Res. 2003 Mar;27(3):221-9. doi: 10.1016/s0145-2126(02)00096-6. Leuk Res. 2003. PMID: 12537974

3

Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?

Sieglová Z, Zilovcová S, Cermák J, Ríhová H, Brezinová D, Dvoráková R, Marková M, Maaloufová J, Sajdová J, Brezinová J, Zemanová Z, Michalová K. Sieglová Z, et al. Among authors: cermak j. Leuk Res. 2004 Oct;28(10):1013-21. doi: 10.1016/j.leukres.2003.11.020. Leuk Res. 2004. PMID: 15289012

4

Erythropoietin administration may potentiate mobilization of storage iron in patients on oral iron chelation therapy.

Cermák J. Cermák J. Hemoglobin. 2006;30(1):105-12. doi: 10.1080/03630260500455375. Hemoglobin. 2006. PMID: 16540422 Clinical Trial.

5

Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts.

Cermak J, Kacirkova P, Mikulenkova D, Michalova K. Cermak J, et al. Leuk Res. 2009 Nov;33(11):1469-74. doi: 10.1016/j.leukres.2009.06.033. Epub 2009 Jul 30. Leuk Res. 2009. PMID: 19646756

6

Nature of frequent deletions in CEBPA.

Fuchs O, Kostecka A, Provaznikova D, Krasna B, Brezinova J, Filkukova J, Kotlin R, Kouba M, Kobylka P, Neuwirtova R, Jonasova A, Caniga M, Schwarz J, Markova J, Maaloufova J, Sponerova D, Novakova L, Cermak J. Fuchs O, et al. Among authors: cermak j. Blood Cells Mol Dis. 2009 Nov-Dec;43(3):260-3. doi: 10.1016/j.bcmd.2009.07.001. Epub 2009 Aug 3. Blood Cells Mol Dis. 2009. PMID: 19651529

7

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Dostalova Merkerova M, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J. Dostalova Merkerova M, et al. Among authors: cermak j. Eur J Hum Genet. 2011 Mar;19(3):313-9. doi: 10.1038/ejhg.2010.209. Epub 2010 Dec 8. Eur J Hum Genet. 2011. PMID: 21150891 Free PMC article.

8

Surface plasmon resonance biosensor for the detection of VEGFR-1--a protein marker of myelodysplastic syndromes.

Pimková K, Bocková M, Hegnerová K, Suttnar J, Cermák J, Homola J, Dyr JE. Pimková K, et al. Among authors: cermak j. Anal Bioanal Chem. 2012 Jan;402(1):381-7. doi: 10.1007/s00216-011-5395-3. Epub 2011 Sep 20. Anal Bioanal Chem. 2012. PMID: 21931953

9

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia.

Májek P, Reicheltová Z, Suttnar J, Cermák J, Dyr JE. Májek P, et al. Among authors: cermak j. Proteome Sci. 2011 Oct 5;9:64. doi: 10.1186/1477-5956-9-64. Proteome Sci. 2011. PMID: 21975265 Free PMC article.

10

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.

Májek P, Reicheltová Z, Suttnar J, Cermák J, Dyr JE. Májek P, et al. Among authors: cermak j. Proteome Sci. 2012 May 8;10(1):31. doi: 10.1186/1477-5956-10-31. Proteome Sci. 2012. PMID: 22568928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page